AstraZeneca | The World Health Organization recommends continuing the vaccination “for the time being”

(Geneva) The World Health Organization continues to recommend vaccination “for the time being” with the AstraZeneca vaccine against COVID-19, which has been suspended for use by many countries due to possible side effects, pending the completion of their evaluation by experts. .




France Media

“At the present time, the World Health Organization believes that the risk / benefit balance is tilted in favor of the AstraZeneca vaccine and recommends continuing vaccinations,” refers on Wednesday to a press release issued by the United Nations agency, specifying that its experts, who are eagerly awaiting their opinion, continue to “evaluate” Data regarding health problems faced by some people vaccinated with this product.

The World Health Organization did not mention when its experts, who met on Tuesday, announced their findings.

Strongly convinced of the advantages

Like the World Health Organization, which has repeated the same message since last week, the European Medicines Agency (EMA) also reiterated Tuesday that it is “fully convinced” of the benefits of the AstraZeneca vaccine against COVID-19.

About fifteen countries, including Germany, France and Italy, have stopped using the AstraZeneca vaccine as a precaution, after reports of blood problems discovered in people who were vaccinated, such as difficulty clotting or forming blood. At this stage.

In its brief press release, the World Health Organization also confirms that no link has been identified yet and specifies that “thromboembolism events are frequent” and that venous thromboembolism is the third cause.H The most common cardiovascular disease.

See also  COVID-19: New world record for cases, 1 billion doses taken | Corona Virus

Earlier, during a press briefing by the WHO committee responsible for making recommendations on the use of vaccines, known as SAGE, technical advisor, Dr. Annelies Wilder Smith, explained that during clinical trials of another anti-COVID – 19 vaccine, Johnson & Johnson vaccine , 10 patients in the placebo group had a blood clot episode compared to 14 in the group who received an injection of the vaccine.

She stressed that out of 44 thousand people who participated in the experiment, this difference in 4 people “is not significant.”

Leave a Reply

Your email address will not be published. Required fields are marked *